ArticleThoracic cancer2022
Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited-stage small-cell lung cancer.
Meng Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it